Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other financing activities (2023)

Perspective Therapeutics (CATX) has disclosed Other financing activities for 2 consecutive years, with $65000.0 as the latest value for Q1 2023.

  • Quarterly Other financing activities changed N/A to $65000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Dec 2023, up 1146.17% year-over-year, with the annual reading at $65000.0 for FY2023, N/A changed from the prior year.
  • Other financing activities hit $65000.0 in Q1 2023 for Perspective Therapeutics, up from $5216.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $65000.0 in Q1 2023 to a low of $65000.0 in Q1 2023.